Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 9INDUSTRY 3

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Neoplasms 2870Carcinoma, Non-Small-Cell Lung 2420Breast Neoplasms 2065Colorectal Neoplasms 1239Neoplasm Metastasis 1223Prostatic Neoplasms 1076Melanoma 972Multiple Myeloma 960Ovarian Neoplasms 899Recurrence 849Leukemia, Myeloid, Acute 807Lung Neoplasms 756Pancreatic Neoplasms 750Lymphoma, Non-Hodgkin 726Lymphoma 660Stomach Neoplasms 622Carcinoma, Hepatocellular 564Carcinoma, Renal Cell 544Squamous Cell Carcinoma of Head and Neck 525Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 449Glioblastoma 435Advanced Solid Tumors 430Small Cell Lung Carcinoma 408Triple Negative Breast Neoplasms 407Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 367Advanced Solid Tumor 349

Interventions

Bioseal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Vascular Malformations × Clear all
NCT06239480 2026-03-27

SELVA

Palvella Therapeutics, Inc.

Phase 3 Active not recruiting
51 enrolled

Congenital Abnormalities, Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

NCT06456125 2024-06-17

OPAL

LVD Biotech S.L

Phase NA Active not recruiting
70 enrolled

Aneurysm, Hemorrhage, Varicose Veins, Aneurysm, False, Vascular Malformations

NCT03110783 2019-11-18

Bioseal Dural Sealing Study BIOS-14-001

Guangzhou Bioseal Biotechnology Co., Ltd.

Phase 3 Completed
200 enrolled

Neoplasms, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡